tiprankstipranks
Hepion Pharmaceuticals (HEPA)
NASDAQ:HEPA

Hepion Pharmaceuticals (HEPA) Financial Statements

700 Followers

Hepion Pharmaceuticals Financial Overview

Hepion Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-9.407; its P/E ratio is -0.11; Hepion Pharmaceuticals is scheduled to report earnings on May 15, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -5.18M$ -11.43M$ -10.52M$ -14.08M$ -13.26M
EBITDA$ -5.15M$ -11.42M$ -10.51M$ -14.06M$ -13.24M
Net Income Common Stockholders$ -2.85M$ -11.06M$ -10.53M$ -14.08M$ -13.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 13.11M$ 14.79M$ 19.28M$ 30.52M$ 42.99M
Total Assets$ 15.99M$ 18.09M$ 25.00M$ 36.50M$ 49.50M
Total Debt$ 175.27K$ 209.02K$ 241.54K$ 0.00$ 0.00
Net Debt$ -12.93M$ -14.58M$ -19.04M$ -30.52M$ -42.99M
Total Liabilities$ 8.47M$ 10.81M$ 8.84M$ 10.13M$ 12.34M
Stockholders Equity$ 7.52M$ 7.28M$ 16.16M$ 26.37M$ 37.15M
Cash Flow-
Free Cash Flow$ -3.60M$ -9.00M$ -11.20M$ -12.52M$ -8.26M
Operating Cash Flow$ -3.60M$ -9.00M$ -11.20M$ -12.50M$ -8.26M
Investing Cash Flow-$ -348.00$ 2.58K$ -16.54K$ 48.43K
Financing Cash Flow$ 1.85M$ 4.49M---
Currency in USD

Hepion Pharmaceuticals Earnings and Revenue History

Hepion Pharmaceuticals Debt to Assets

Hepion Pharmaceuticals Cash Flow

Hepion Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis